Massachusetts General Hospital/Harvard Medical School
Boston, Massachusetts, United States
Helen Shih, MD, MS, MPH, FASTRO is a radiation oncologist with multiple interest in clinical care, research, education, and administrative leadership. She is a Professor of Radiation Oncology at Massachusetts General Hospital and Harvard Medical School. Her clinical practice comprises of patients with malignant and benign CNS tumors, ocular tumors, and additional nontumor conditions that may benefit from radiation therapy. Her research interests reflect her patient population, specifically to improve patient care and outcomes, reduce radiation treatment related toxicity, and to advance radiotherapy tools with specific attention to the role of proton therapy. She is the Medical Director of the MGH Proton Therapy Centers. She serves on the SNO Board of Directors as the radiation oncology representative, has been actively involved in the America Society of Radiation Oncology (ASTRO) in multiple leadership roles, including past annual meeting CNS scientific chair to current Scientific Review and Nominations Committees. She chaired the ASTRO guidelines on radiation therapy role in lower grade glioma management, is on the Board of the Radiosurgery Society and is an active member of the ASCO Guideline Advisory Group. Beyond radiation oncology, Dr. Shih has a second passion in drug addiction which spans education, prevention, treatment, community leadership, and research.
